In today’s briefing:
- FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?
- Hong Kong CEO & Director Dealings: 21st Oct: Impro Precision, Wealthking, C C Land, China Bright
- ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate
FDR’s Trade Embargo on Oil (Japan) & Biden’s Sanctions on China’s Semi Sector – Prelude to Disaster?
- In the past couple of weeks, there have been tremendous sanctions by the US government on China’s semiconductor sector.
- In this insight, we compare this move to the US government putting a trade embargo on oil against Japan nearly 81 years ago.
- If there are severe disruptions to the semiconductor market in China, this will likely to have negative impact on the two Korean semi giants Samsung Electronics and SK Hynix.
Hong Kong CEO & Director Dealings: 21st Oct: Impro Precision, Wealthking, C C Land, China Bright
- The data in this insight is collated from the “shareholding disclosure” link on the HKEx website.
- Often there is a corresponding HKEx announcement on the increase – or decrease – in the shareholding by directors. However, such disclosures are by no means an absolute.
- These insights may flag those companies where shares have been pledged. Stocks mentioned include Impro (1286 HK), Wealthking (1140 HK), C C Land (1224 HK), and China Bright (1859 HK).
ECM Weekly (23rd Oct 2022) – Giant Biogene, Blibli, Bionote, Fusion Micro, Mitsubishi Estate
- Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
- On the IPO front, Blibli launched its Indonesian IPO, while a few other names are said to be gearing up to launch in Hong Kong and India.
- There were a few placements this week, notable ones being Mitsubishi Estate Logistics (3481 JP) and Zee Entertainment Enterprises (Z IN).
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars